Lotus Pharma Starts China Clinical Trial of Asthma Drug

Lotus Pharmaceuticals has begun a Phase I trial of R-Bambuterol®, an asthma treatment. The company said preclinical studies of R-Bambuterol showed efficacy but lower toxicity than Bambuterol, which can cause liver and cardiovascular side effects. Bambuterol is already commercially available in China. More details.... Stock Symbol: (OTCBB: LTUS)